Clinical Trials for Imatinib (Gleevec)

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCBMT1148
05/11/2012
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Cell Transplantation (Consortium)

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.